Metlife (MET) Issues Earnings Results
Metlife (NYSE:MET) released its earnings results on Tuesday. The financial services provider reported $0.64 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.05 by ($0.41), Bloomberg Earnings reports. Metlife had a positive return on equity of 8.81% and a negative net margin of 0.75%. During the same quarter in the previous year, the company posted $1.28 earnings per share.
Metlife (NYSE:MET) opened at $45.00 on Wednesday. The company has a market cap of $47,560.00, a price-to-earnings ratio of 10.41, a P/E/G ratio of 1.00 and a beta of 1.31. Metlife has a twelve month low of $43.38 and a twelve month high of $55.91. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.31.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 13th. Investors of record on Monday, February 5th will be issued a $0.40 dividend. The ex-dividend date of this dividend is Friday, February 2nd. This represents a $1.60 annualized dividend and a yield of 3.56%. Metlife’s dividend payout ratio (DPR) is presently 36.87%.
TRADEMARK VIOLATION NOTICE: This story was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this story on another website, it was illegally stolen and republished in violation of U.S. and international copyright & trademark legislation. The original version of this story can be viewed at https://www.thecerbatgem.com/2018/02/14/metlife-met-issues-earnings-results.html.
Metlife Company Profile
MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.
Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.